Incidence and degree of respiratory disorders in patients with arterial hypertension depending of smoking duration


  • O.B. Voloshyna Odessa National Medical University, Odesa, Ukraine,
  • T.O. Dychko Odessa National Medical University, Odesa, Ukraine,
  • I.S. Lysyy Odessa National Medical University, Odesa, Ukraine,
  • V.O. Zbitneva Odessa National Medical University, Odesa, Ukraine,



тютюнопаління, показники спірометрії, артеріальна гіпертензія


Background. Prolonged tobacco smoking often leads to the development of chronic obstructive pulmonary disease and cardiovascular diseases. The purpose of this work was to determine the incidence and degree of respiratory disorders in patients with arterial hypertension depending on the duration of smoking. Materials and methods. The study included 80 patients with established diagnosis of degree I–III arterial hypertension without a history of obstructive pulmonary disease. The control group consisted of patients with hypertension who never smoked (n = 52), the main group was represented by patients who smoked in the past or are currently smoking (n = 28). Collection of anamnestic data and complaints, anthropometric data analysis, smoking index, office and home monitoring data, lung ventilation results was performed in all patients. Results. According to the obtained results, the patients with arterial hypertension and smoking history ≥ 10 pack-years were significantly more likely to have breathing dysfunction (11.3 %; p < 0.05) than patients who do not smoke (only 3.8 %). The analysis of correlation revealed statistically significant inverse relationship between smoking history ≥ 10 pack-years and increased ratio of forced expiratory volume in one second to forced vital capacity: in men — r = 0.8052 (p < 0.01), in females — r = — 0.69154 (p < 0.01). Conclusions. Thus, for the timely detection of concomitant pathology and the prescription of adequate therapies, at the stage of primary care it can be proposed to perform measurements of respiratory function in all smoker patients with arterial hypertension and history of smoking of more than 10 pack-years.


Фещенко Ю.І. Проблема ХОЗЛ у світі і Україні: що є каменем спотикання на шляху до її вирішення / Ю.І. Фещенко // Здоров’я України. — 2011. — № 21(274). — С. 28-29.

Мостовой Ю.М. Проблема коморбідних станів у Національній угоді з діагностики та лікування хронічного обструктивного захворювання легень із позиції власного досвіду. Обговорення Наказу № 555 / Ю.М. Мостовой, Л.В. Распутіна // Буковинський медичний вісник. — 2014. — Т. 18, № 3. — С. 221-226.

Sin D.D., Man S.F.P. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease // Circulation. — 2003. — 107. — Р. 1514-1519.

Anthonisen N.R., Connett J.E., Enright P.L., Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study // Am. J. Respir. Crit. Care Med. — 2002. — 166. — Р. 333-9.

Наказ МОЗ України № 555 від 27.06.2013 р. «Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при хронічному обструктивному захворюванні легень». — Київ, 2013. — 146 с.



Internal diseases